Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhiguo Luo
Observed names:
Z. Luo,
Z.G. Luo,
Zhi-Guo Luo
Institutions:
Hubei University of Medicine,
Fudan University,
Fudan University Shanghai Cancer Center,
Taihe Hospital
Observed institutions:
Hubei University of Medicine,
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Taihe Hospital
ORCID:
0009-0008-7710-6491
Observed ORCID:
0009-0008-7710-6491
OpenAlex ID:
A5114027273
Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma
2008
·
Xin Liu
, Xiao-Nan Hong
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
71
Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma
2024
·
Ni Jiang
, Dan Li
, et al.
·
Aging
·
5
Abstract CT208: Tebotelimab, a PD-1/LAG-3 bispecific antibody, in patients with untreated, unresectable, recurrent or metastatic, mucosal melanoma: An open-label, single-arm, Phase 1 study
2023
·
Si Lu
, Yu Chen
, et al.
·
Cancer Research
·
4
Advanced Breast Angiosarcoma Completely Responding to Gemcitabine-Containing Chemotherapy
2012
·
Zhi-Guo Luo
, Qian Wang
, et al.
·
Breast Care
·
4
Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
2024
·
Min Jin
, Hong-Li Liu
, et al.
·
The Oncologist
·
3
67P Sintilimab, doxorubicin and ifosfamide (AI) as first-line treatment in patients with advanced soft tissue sarcoma: A single-arm phase II trial
2021
·
Z. Luo
, X. Liu
, et al.
·
Annals of Oncology
·
3
P-172 A multi-center, open-label, randomized controlled trial of nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine for first-line treatment of advanced pancreatic cancer (PC)
2022
·
M. Jin
, H. Liu
, et al.
·
Annals of Oncology
·
2
Correlation of cell cycle–related kinase and SII with FIGO stage, lymph node metastasis, and prognosis of serous ovarian cancer
2025
·
Yu Chen
, Li Yuan
, et al.
·
Indian Journal of Cancer
·
1
A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer.
2022
·
Jinlin Wang
, Tienan Yi
, et al.
·
Journal of Clinical Oncology
·
1
PD-1 blockade in combination with bevacizumab and nab-paclitaxel for second-line treatment in cancer of unknown primary (Fudan CUP-002): A prospective, single-arm phase II study.
2025
·
Zhiguo Luo
, Xiaowei Zhang
, et al.
·
Journal of Clinical Oncology
PDF
GRAP2 is a Prognostic Biomarker and Correlated with Immune Infiltration in Lung Adenocarcinoma
2022
·
Shimao Song
, Xinzhou Deng
, et al.
·
Research Square
Continuous Infusion of Endostar Combined with Chemotherapy in Patients with Advanced or Recurrent Mucosal Melanoma: A Real-World Cohort Study
2021
·
Xiaowei Zhang
, Feng Jin
, et al.
·
Research Square
PDF
440P Association of glucocorticoid receptor expression with the treatment outcome of pemetrexed-based chemotherapy in NSCLC patients
2015
·
X. Zhao
, J. Wang
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
13
Citation count:
94
H-index:
4
I10-index:
1
Year
Topic
Type